ACE and cardiomyopathy: Previousevidence-based studies providing that angiotensin converting enzyme inhibitors(ACEI), angiotensin receptor blockers, beta-blockers and/or aldosteroneantagonists might improve or preserve left ventricular systolic function and maydelay the progression of cardiomyopathy [26, 27, 28, 29, 30, 31].